Content about tenofovir disoproxil fumarate

April 4, 2013

FDA grants tentative approval to Aurobindo HIV drug

The Food and Drug Administration has given preliminary approval to a drug made by Aurobindo Pharma for treating HIV infection, the drug maker said.

August 3, 2012

Mylan, Gilead sign HIV/AIDS drug deal

Mylan and Gilead Sciences have made an agreement under which Mylan will have rights to produce and market generic versions of Gilead drugs for HIV and AIDS in developing countries.

July 16, 2012

Gilead's Truvada approved for PrEP

The Food and Drug Administration has approved a drug used to treat HIV for reducing the risk of HIV infection, the agency said Monday.

June 29, 2012

Gilead seeks approval for HIV drug-boosting agent

Drug maker Gilead Sciences has submitted a regulatory approval application to the Food and Drug Administration for a drug designed to increase the blood levels of certain drugs for HIV.

May 14, 2012

FDA panel recommends approval for experimental Gilead HIV drug

A Food and Drug Administration expert panel has recommended approval of a drug made by Gilead Sciences for treating HIV, the drug maker said Friday.

May 11, 2012

FDA advisory committee recommends PrEP approval for Truvada

An expert panel at the Food and Drug Administration has recommended that the agency approve a drug made by Gilead Sciences for lowering the risk of infection by the virus that causes AIDS.

May 9, 2012

Reports: FDA may be close to approving drug for HIV prevention

The Food and Drug Administration may be close to approving a drug for preventing HIV infection, according to published reports.

February 14, 2012

FDA grants priority review to Gilead's Truvada for HIV prevention

The Food and Drug Administration is giving priority review to a drug made by Gilead Sciences that the company is investigating for the prevention of HIV.

January 19, 2012

Gilead receives FDA approval for lower-dose HIV drug in children

The Food and Drug Administration has approved a lower-dose formulation of a drug made by Gilead Sciences for treating HIV in children, the company said.

December 20, 2011

WHO approves Mylan generic HIV drugs for use in developing world

The World Health Organization has approved three generic second-line treatments for HIV made by Mylan, the drug maker said Tuesday. The drugs will be delivered to people in developing countries living with HIV and AIDS.

August 11, 2011

FDA approves single-pill HIV drug

The Food and Drug Administration has approved a new single-pill treatment for HIV made by Gilead Sciences and Johnson & Johnson, Gilead said.

September 12, 2010

Gilead: 'Quad' anti-retroviral drug as effective as competitor

An investigational treatment for HIV by Gilead Sciences that combines four drugs in one tablet...